BENEFIT-RISK RATIO

被引：0
|
作者：
TICE, LF
机构：
来源：
AMERICAN JOURNAL OF PHARMACY | 1977年 / 149卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [1] Tetrabamate and a benefit-risk ratio
    Lucena, MI
    Andrade, RJ
    García-Ruiz, E
    Madurga, M
    MEDICINA CLINICA, 2002, 118 (12): : 477 - 477
  • [2] Splendours and miseries of the benefit-risk ratio
    Dupuy, A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2010, 137 (04): : 267 - 268
  • [3] THIAZIDES - THE TRUE BENEFIT-RISK RATIO
    GREENWOOD, RJ
    HOSPITAL PRACTICE, 1990, 25 (10A): : 16 - &
  • [4] BENEFIT-RISK RATIO FOR BIOLOGICAL PRODUCTS
    HARRIS, LE
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1968, 152 (01) : 31 - &
  • [5] THIAZIDES - THE TRUE BENEFIT-RISK RATIO - REPLY
    FREIS, ED
    HOSPITAL PRACTICE, 1990, 25 (10A): : 19 - &
  • [6] Qualitative and Quantitative Assessment of the Benefit-Risk Ratio of Medium Potency Topical Corticosteroids In Vitro and In VivoCharacterisation of Drugs with an Increased Benefit-Risk Ratio
    Carolin Schackert
    Hans Christian Korting
    Monika Schäfer-Korting
    BioDrugs, 2000, 13 : 267 - 277
  • [7] Chiral switch: Towards a better benefit-risk ratio?
    Blin, O
    THERAPIE, 2004, 59 (06): : 625 - 628
  • [8] Antidepressant use during pregnancy: the benefit-risk ratio
    Koren, Gideon
    Nordeng, Hedvig
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (03) : 157 - 163
  • [9] From immunosuppression to selective treatments: The benefit-risk ratio
    Guillevin, Loic
    PRESSE MEDICALE, 2013, 42 (04): : 641 - 643
  • [10] Bromocriptine and inhibition of lactation: review of the benefit-risk ratio
    Vuillet-A-Ciles, Hadrien
    Pillon, Francois
    ACTUALITES PHARMACEUTIQUES, 2014, 53 (536): : 45 - 47
12345